Price Chart

Profile

Dyne Therapeutics Inc is a biotechnology company focused on providing therapeutics for patients with genetically driven diseases.  The company overcomes the limitations of muscle tissue delivery and modern oligonucleotide therapeutics for muscle diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy. The company's product candidates are DYNE-101 and DYNE-251, both are in the ongoing phase 1/2 clinical trial.
URL https://www.dyne-tx.com
Investor Relations URL https://investors.dyne-tx.com/
HQ State/Province Massachusetts
Sector Health Care
Industry Biotechnology
Equity Style Small Cap/Growth
Next Earnings Release Mar. 05, 2025 (est.)
Last Earnings Release Nov. 12, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Dyne Therapeutics Inc is a biotechnology company focused on providing therapeutics for patients with genetically driven diseases.  The company overcomes the limitations of muscle tissue delivery and modern oligonucleotide therapeutics for muscle diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy. The company's product candidates are DYNE-101 and DYNE-251, both are in the ongoing phase 1/2 clinical trial.
URL https://www.dyne-tx.com
Investor Relations URL https://investors.dyne-tx.com/
HQ State/Province Massachusetts
Sector Health Care
Industry Biotechnology
Equity Style Small Cap/Growth
Next Earnings Release Mar. 05, 2025 (est.)
Last Earnings Release Nov. 12, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A